Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




ADLM Updates Expert Guidance on Urine Drug Testing for Patients in Emergency Departments

By LabMedica International staff writers
Posted on 08 Jan 2026

Urine drug testing plays a critical role in the emergency department, particularly for patients presenting with suspected overdose or altered mental status. More...

Accurate and timely results can directly influence clinical decisions, prevent unnecessary imaging, and trigger safeguarding actions in vulnerable populations such as children. As patterns of drug misuse and available testing technologies have changed significantly, up-to-date guidance is essential to ensure testing remains clinically meaningful.

The Association for Diagnostics & Laboratory Medicine (ADLM, Chicago, IL, USA) has released its updated guidance to help healthcare professionals navigate drug testing for patients in the emergency department. The recommendations were developed by experts from ADLM’s Academy of Diagnostics & Laboratory Medicine to help emergency clinicians and laboratory professionals choose appropriate drug tests for both adult and pediatric patients. The guidance emphasizes collaboration between laboratories and emergency departments to optimize test selection, interpretation, and patient care.

Since ADLM first issued emergency department drug testing guidance in 2003, the drug landscape has changed dramatically. Synthetic opioids such as fentanyl entered the illegal drug supply around 2013, and new designer drugs continue to emerge each year to evade regulation. At the same time, use of some medications, including tricyclic antidepressants, has declined to the point that routine testing is often no longer clinically useful.

The expert group reviewed evolving trends in drug use alongside advances in testing technology. While immunoassays remain the most common method for urine drug testing, their performance has improved over time, and access to mass spectrometry has expanded across healthcare institutions. The updated guidance integrates these developments to ensure test menus and protocols remain aligned with real-world clinical needs.

The guidance recommends close collaboration between laboratories and emergency clinicians, with laboratories actively educating providers on test limitations and interpretation. Institutions are advised to regularly review and update their drug testing menus based on local drug use patterns, removing tests that do not influence patient management. For selected cases, including pediatric patients or situations where immunoassays are insufficient, the use of mass spectrometry is encouraged when results are expected to guide care.

By aligning drug testing practices with current epidemiology and technology, the updated guidance supports more personalized and effective emergency care. The recommendations aim to reduce unnecessary testing, improve diagnostic accuracy, and ensure that results meaningfully inform clinical decisions. ADLM expects the guidance to evolve further as new drugs and testing methods continue to emerge.

The expert panel has emphasized that ongoing communication between laboratories and emergency departments is essential to keep pace with rapidly changing drug trends and to ensure that urine drug testing remains a valuable tool in emergency medicine.

"Regardless of the method(s) offered, all laboratories should collaborate with ED leadership … to ensure test menus are up to date and reasonable for the patient population," wrote the document authors. Additionally, "laboratories and EDs should collaborate on education of clinical staff regarding assay performance and limitations and regularly discuss optimal strategies to meet clinical needs."

Related Links:
ADLM


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.